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Arsenic, though a poor mutagen, is an accepted environmental carcinogen. Perturbation of DNA methylation
pattern leading to aberrant gene expression has been hypothesized as the mechanism for arsenic induced
carcinogenesis. We had earlier demonstrated the hypermethylation of promoter region of p53 and p16 genes in
persons exposed to different doses of arsenic. Till now no genomic hot spot has been identified which is frequently
hypermethylated or hypomethylated in persons chronically exposed to environmental arsenic. In the present work,
we have identified one hypermethylated sequence by methyl-sensitive arbitrarily primed polymerase chain reaction
in the peripheral blood leukocyte DNA of chronically arsenic exposed persons with and without arsenic induced
skin cancer. The sequence is from GMDS gene responsible for fucose metabolism. Southern hybridization of the
sequence to the amplification products of methyl sensitive restriction enzyme digested genome of persons
exposed to different doses of arsenic indicated that methylation increased in a dose dependent manner.
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According to (International agency for research on
cancer 1997) and National Research Council (NRC 1999)
arsenic is an important environmental toxicant and
carcinogen. However, the mechanism of arsenic mediated
carcinogenesis is not clear as arsenic is a poor mutagen
(Rossman et al. 1980; Jacobson and Moltanbano 1985;
Lee et al. 1985) and does not induce significant point
mutations. Biotransformation of arsenic, on the other
hand, involves methylation of inorganic arsenic to
organic monomethyl arsonic acid (MMA) and dimethyl arsi-
nic acid (DMA), using the same methyl donor S-Adenosyl
methionine (SAM) also involved in DNA methylation
(Vahter 1999). The interference of the DNA methylation
pathway with arsenic detoxification pathway, as both
the pathways require SAM, can lead to aberrant DNA
methylation, resulting aberrant expression and/or silen-
cing of genes Goering et al. (1999). Therefore, epigenetic* Correspondence: csarmishtha@yahoo.com
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in any medium, provided the original work is palterations, particularly aberrant DNA methylation has
been mooted as a possible mechanism of arsenic induced
carcinogenesis (Ren et al. 2010; Reichard and Puga 2010).
Cytosine-5 methylation at the CpG islands in the regula-
tory sequence of a gene is one of the key mechanisms of
gene inactivation. DNA methylation/demethylation seems
to regulate a plethora of biological processes involving
transcription, differentiation, development, DNA repair,
recombination, and chromosome organization. Perturbation
of DNA methylation has been correlated with many cases
of cancer (Jones and Baylin 2002). The hypothesis that
arsenic perturbs DNA methylation has been tested success-
fully on tissue culture system (Mass and Wang 1997), and
later we demonstrated hypermethylation of the promoter
region of p53 and p16 genes in DNA extracted from
peripheral blood leucocytes of persons exposed to
different doses of arsenic (Chanda et al. 2006). A few
highly exposed persons also showed p53 hypomethylation
(Chanda et al. 2006). Further arsenic induced genome wide
hypermethylation has been demonstrated by us in DNA
extracted from same population Majumder et al. (2010).
In this report we have further evaluated the hypothesis
on a subsection of exposed population studied by isolatingan open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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exposed persons by methyl sensitive arbitrarily primed
polymerase chain reaction (MS-AP-PCR). Differentially
methylalated fragments have been identified and isolated
from chronically arsenic exposed people. 7 persons of ar-
senic induced skin cancer out of 16 (all the cancer patients
were recruited from previous study, Chanda et al. 2006),
have one common hypermethylated fragment of 565 bp
(this was cloned and sequenced). The same sequence was
also isolated from 3 chronically arsenic exposed persons
out of 10 (all of these 10 subjects were recruited from pre-
vious study, Chanda et al. 2006). The sequence is then
analysed by bioinformatic tools (NCBI BLAST) to indicate
that the fragment is actually situated in the human GDP
mannose 4–6 dehydratase gene (GMDS gene). Southern
hybridization of this fragment to amplified products from
methyl sensitive restriction enzyme digested genomic
DNA of persons exposed to arsenic in drinking water indi-
cated that the sequence is indeed hypermethylated. The
product of the identified gene is involved in fucose metab-
olism and it is reported that deletion of this gene results
in cancer progression (Thompson et al. 1992; Becker and
Lowe 2003; Yuan et al. 2008). Though have been found
here in small proportion this hypermethylated fragment
may be act as a potential target (probe) for detecting aber-
rant methylation in chronic high level of arsenic exposure.
Materials and methods
Subject selection
Subjects of this study were the same set of our earlier study
on arsenic induced DNA hypermethylation in p53 and p16
gene promoter region and are all residents of South & North
24 Parganas, West Bengal, India (Chanda et al. 2006).
Criteria of diagnosis of arsenicosis and its severity are
based on the parameters described earlier (GuhaMazumder
et al. 1998; GuhaMazumder 2001; Chanda et al. 2006). In
this study only the subjects for p53 gene promoter
hypermethylation group of the previous study had
been chosen. Participants had been divided into the
five groups A, B, C, D according to the concentration
of arsenic in their drinking water, i.e. 0–50, 51–250,
251–500, 501–1000 μg/l respectively as earlier and
group E with 500–1100 μg/l of arsenic suffering from
arsenic induced skin cancer. As the concentration of
arsenic in group A is within the permissible limit according
to WHO and Medical Council of India, it was considered
as the unexposed control group (NRC 1999). Initially the
number of participants in each group was 24, 12, 18,
15 and 16 in A, B, C, D and E group respectively
(Chanda et al. 2006). Among those, 11 subjects in group C,
10 subjects in group D and all the 16 subjects in group E
were chosen for this study. All of the subjects
chosen for MS-AP PCR have hypermethylated p53
promoter region compared to normal unexposedpersons (Chanda et al. 2006). All of the subjects studied for
MS-AP-PCR were compared to normal unexposed subjects
treated in similar way. In this study 12 of the normal
unexposed subjects were recruited from group A.
The initial studies on isolation of hyper/hypo methylated
stretch of genomic DNA was performed with peripheral
blood leukocyte DNA of highly arsenic exposed persons of
group D and arsenic induced cancer group, E. Later, lower
exposure group C was also evaluated for the presence of
such hyper/hypomethylated gene fragments. Among 16 of
the cancer patients (group E) studied, 7 had a hypermethy-
lated DNA fragment of 565 nucleotide long sequence.
Among 10 subjects of group D, 3 had that hypermethylated
fragment. The fragment identified was from the partici-
pants of group D and group E but not from any lower
exposure group. Although there is an overlap between
group D and E in respect to the concentration of arsenic in
water but the difference is one group have arsenic induced
skin cancer with higher degree of skin manifestations
(group E) while the other group (group D) is only character-
ized by higher degree of skin manifestations without cancer.
The identified and isolated hypermethylated fragment was
then sequenced. The sequence is from the intronic region
of human GMDS gene situated in between exon 1 and 2.
The southern hybridization studies of the identified frag-
ment with DNA of 4 persons, taken 1 from each exposure
group indicate that the sequence is indeed hypermethylated.
Demographic data for this study population is described in
detail (Table 1). Once the fragment was identified and
isolated from peripheral blood leukocyte DNA of arsenic
induced cancer patients, the procedure was cross-checked
using DNA samples isolated from cancer biopsy samples
of the same patients. But it was not done in case of
group D samples due to lack of biopsy tissues in those
cases (as these are not arsenic induced cancer).
Written informed consent was obtained from all
participants before drawing their blood. The name of
the institute where human clinical studies were carried
out is Institute of Post Graduate Medical Education and
Research, Kolkata (IPGME&R), which is run by Govt. of
West Bengal, a state government within the framework of
Republic of India.
Molecular Biological and in silico experiments were
carried out in University of Calcutta and Presidency
University, Kolkata which are also run by Govt. of West
Bengal. Ethical principles followed by the institute are
guided by rules as formulated by Indian Council of
Medical Research and these are in agreement with
Helsinki declaration.
Determination of Arsenic concentration in urine
and water
Level of arsenic in drinking water and urine was de-
termined by atomic absorption spectrophotometer
Table 1 Demographic data of study subjects taken from different arsenic exposure groups
Age group Sex Group A (0-50 μg/l)
p53 methylation
Group C (250-500 μg/l)
p53 methylation
Group D (501-1000 μg/l)
p53 methylation
Group E (500-1100 μg/l)
p53 methylation
<20 years Male N = 2; 0.08, 0.19 N = 2; 1.34, 1.62
Female N = 2; 1.50, 1.45
21-40 years Male N = 3; 0.03, 0.23, 0.15 N = 3; 1.50, 2.78, 5.00 N = 4; 1.95, 2.04, 4.3 2.46 N = 3; 0.85, 1.09, 1.32
Female N = 1; 0.15 N = 1; 2.56 N = 3; 1.00, 1.62, 1.09
41-60 years Male N = 3;0.18, 0.27, 0.27 N = 2; 1.56, 2.4 N = 2; 2.85, 4.46 N = 4; 1.42, 3.08, 2.09, 2.09
Female N = 3; 0.08, 0.09, 0.32 N = 2; 1.95, 4.66 N = 2 4.45, 2.7 N = 1; 2.55
>60 years Male N = 1; 2.15 N = 4; 2.20, 2.23, 1.62, 1.60
Female N = 1; 2.11
Smoking status Smoker 8 9 7 11
Nonsmoker 4 2 3 5
Exsmoker
Avarage duration of exposure 11.5 years 15 years 10 years 17 years
Total number of samples 47/M 12 11 10 16
Note: numerical values in each cell indicate the degree of p53 methylation for individual study subjects recruited in the study.
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Kalman (1991).
DNA isolation from blood
DNA was extracted from whole blood by conventional
chloroform extraction method using 0.01% SDS and
Proteinase K (0.1 mg/ml) (Miller et al. 1998).
DNA isolation from tissue
DNA was extracted from cancer biopsy tissue samples
by conventional phenol-chloroform (1: 1, v/v) extraction
method and then by chloroform extraction followed by
salting out using 0.01% SDS and Proteinase K (0.1 mg/ml)
(Miller et al. 1998).
p53 methylation status analysis
The p53 tumor suppressor gene methylation status was
analyzed in each subject by the method described earlier
(Chanda et al. 2006).
Determination of clinical symptom score
Each subject was assigned a clinical symptom score
which reflects the severity of his/her skin manifestations.
Both pigmentation and keratosis were graded as 1,2 or 3,
depending on the level and severity of symptoms. Sum of
the two was clinical symptom score, so that a person can
have maximum score of 6. Control subjects have no
pigmentation and keratosis and therefore have a clinical
symptom score 0. The detail structure of the scoring
system for pigmentation and keratosis is given in Table 2.
Restriction enzyme digestion for arbitrarily primed PCR
Concentration and quality of isolated genomic DNA was
determined UV–vis spectrophotometer (OD 260/280 >1.8).300 ng of total genomic DNA isolated from persons,
unexposed/exposed to arsenic through drinking water,
was digested with 5 units of RsaI and 5units of HpaII
restriction enzyme at 37°C overnight. HpaII is a methyla-
tion sensitive isoshizomer of MspI whose recognition
sequence is CCGG. A sequence hypermethylated at this site
would not be digested, whereas the unmethylated DNA
would. The persons taken for MS-AP-PCR were from
higher exposure groups of arsenic (251–500 μg/l, i.e. group
C; 500–1000 μg/l, i.e. group D; and arsenic induced cancer
group, E, with an exposure level of 500–1100 μg/l) and all
have hypermethylated p53 promoter. Out of 18 in group C,
11 subjects were taken for MS-AP-PCR. All have hyper-
methylated p53 promoter region. In group D only 10 sam-
ples were chosen with hypermethylated p53 promoter
having a median value of 2.63. In group E all the 16 samples
were studied with p53 promoter hypermethylation
with a median value of 1.62. The median value for p53
methylation in group A (unexposed control group) was
0.26 which is treated here as a basal value for normal
unexposed persons (Chanda et al. 2006). Demographic
data and p53 methylation values for subjects included in
this study are presented in Table 1.
Methyl sensitive arbitrarily primed PCR (MS-AP- PCR)
When RsaI + HpaII digested DNA was used as template
in MS-AP-PCR using random primers that target
CG-rich DNA sequences (Zhong and Mass 2001), a
series of amplified products were observed. Of these,
a band present in PCR products of arsenic exposed DNA
but absent in PCR products of similarly digested unexposed
DNA represents the region of hypermethylation (Zhong
and Mass 2001). We used 3 different primers. Amongst
these primers, OPN Hind12 (5’-AGCTTCTCCCTC-3’)
Table 2 Dermatological criteria and graduation of chronic arsenic toxicity for scoring sustem of skin manifestations
Pigmentation
Mild 1 Moderate score = 2 Severe score = 3
Defuse Melanosis, Mild Spotty pigmentation,
Leucomelanosis
Moderate Spotty pigmentation Blotchy Pigmentation, Pigmentation of under
surface of tongue, buccal mucosa
Keratosis
Mild Score = 1 Moderate score = 2 Severe score = 3
Slight thickening, or minute papules (<2 cm)
in palm and soles
Multiple raised keratosis papules (2 to 5 cm)
in palm & soles with diffuse thickening
Diffuse severe thickening, large discreet or
confluent keratotic elevations (>5 cm), palm
and soles (also dorsum of extremely and trunk)
The underlined data represents the clinical symptom score.
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induced cancer patients and in highly arsenic exposed
persons when subjected to PCR amplification. The
concentration of OPN Hind 12 in the PCR reaction
mixture was 0.5μM. The PCR protocol was initial de-
naturation at 94°C for 5 minutes, 35 cycles at 94°C
for 1 min, 40°C for 1 min, 72°C for 2 min, followed
by 10 min at 72°C.
Isolation of candidate bands
The PCR products from DNA of arsenic exposed persons
were compared with PCR products from control DNA.
The band, which appears only in the exposed DNA but
not in unexposed DNA was supposed to be region of
hypermethylation. Similarly, band which appears only in
the unexposed control but not in the exposed DNA indi-
cated the site of hypomethylation in the DNA of exposed
persons. Such a region of hypermethylation from chronic-
ally high arsenic exposed people with and without arsenic
induced cancer was identified. The ethidium bromide
stained PCR amplified DNA band was then excised from
the gel by a scalpel and recovered by the usual ‘crush and
soak’ method (Sambrook et al. 1989). The candidate band
isolated from subjects were from group D and E. Clinical
symptom score, p53 methylation status and degree of
arsenic exposure for those subjects are given in Table 3.
DNA cloning in plasmid vector
The gel- recovered PCR product was re-amplified using
the same PCR protocol with same primer. The amplified
product was then purified by ethanol precipitation and
cloned in E.coli XL1 blue strain using pTZ57R/T vector
(TA cloning kit, Fermentas). The positive clones were
identified by performing colony PCR with universal
primers and sequenced.
Southern hybridization
Exactly equal amount (1.3 μg) of genomic DNA of four per-
sons from four different exposure groups (Group A, B, C, D)
were subjected to restriction digestion by RsaI and
HpaII and incubated overnight at 37°C. Each of thedigested products was then subjected to PCR amplification
using primer OPN Hind12. The PCR products obtained
from four different DNA samples were resolved by electro-
phoresis on a 2% agarose gel. The gel was blotted on nylon
membrane using standard technique and then hybridized
with α- P32 dCTP (BARC, India) labelled clone insert. The
same procedure of hybridization was carried out using one
DNA sample from cancer patient where instead of group
A, B, C, D group B,C, D and E were used to hybridise with
the labelled clone of the fragment isolated. The relevant
parameters for the persons taken from four different
groups for hybridization are described in Table 4.
Result
Using the technique of MS-AP PCR, 1 common hyper-
methylated DNA fragment was identified from 10 different
people with chronic high level of arsenic exposure with and
with out cancer. Among 16 of the arsenic induced cancer
patients studied (belonging to group E) 7 have the hyper-
methylated DNA fragment of 565 nucleotide base pair.
Among 10 of group D subjects 3 have been identified to
harbour this hypermethylated DNA fragment. Demographic
data and p53 methylation status for these 10 subjects
(with hypermethylated DNA) has been listed in Table 3.
Interestingly, people from lower arsenic exposure (group C)
did not have this hypermethylated gene fragment.
The fragment identified is a region of hypermethylation
in comparison to normal unexposed persons. DNA
sequence analysis revealed that the identified fragment
has significant homology match (99%) to the sequence
of human GMDS gene (Accession no. NT_007592.15),
Homo sapiens) (taken from GENEBANK database)
after BLAST search. The sequence is situated in the intron
between exon 1 and 2 of GMDS gene. (Genomic context:
chromosome: 6; Maps: 6p24.1-25.3). It is the longest
intronic sequence in GMDS gene (> 1,80,000 bp). This gene
is involved in carbohydrate metabolism and generation of
fucose. Fucose mediates initial contact between extravagat-
ing leucocytes and endothelial cells. Influence of fucose gen-
erating enzymes on leukocyte adhesion activity has been
reported (Sullivan et al. 1998; Eshel et al. 2001).
Table 3 Demographic data and p53 methylation status of subjects having GMDS gene hypermethylation









KA 261 52/M Non smoker 580 7 ++ + 3 272.8 4.46
Gr. D
DHW 088 43/M smoker 683 5 ++++ 4 89 2.85
Gr. D
CW045 38/M smoker 531 5 ++++ 4 189 2.46
Gr.D
CNBB 33 48/F Non-smoker 826 14 ++++ 4 212 2.55
Gr.E
CNBB 28 40/M Ex smoker 740 10 ++++ 4 126 1.62
Gr.E
A 10 51/M smoker 514 17 ++++ ++ 6 211 3.08
Gr.E
A 15 47/M smoker 623 13 ++++ ++ 6 97 2.09
Gr.E
A 20 53/M smoker 744 10 ++++ 4 143 2.09
Gr.E
A 17 63/M smoker 556 17 ++++ ++ 6 171 2.20
Gr.E
A 21 61/M smoker 631 10 ++++ ++ 6 206 2.23
Gr.E
Note: The pigmentation and keratosis was assigned as a numerical score according to the degree of severity.
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products amplified by the OPN Hind 12 primer from HpaII
digested genomic DNA of persons exposed to various doses
of arsenic and arsenic induced cancer, it was found that the
hybridization increases in higher exposure groups and in
arsenic induced cancer patients. This indicates that the
segment is indeed hypermethylated in genomic DNA of
persons with high arsenic exposure and also in arsenic
induced cancer patients (Figure 1a, 1b). Hypermethylation
rendered the fragment insensitive to digestion by the methyl
sensitive enzyme HpaII at the relevant site in higher expos-
ure group DNA and the desired region was available for
amplification. So the amount of PCR product template avail-
able for associating with the probe is more in the arsenic
exposed group and in cancer group with hypermethylation









1 40/M smoker 11 5
2 47/M smoker 118 5
3 52/M smoker 314 7
4 39/M smoker 644 6Our identified fragment, OPN Aga 8, shows very low
association with the DNA of <50 μg/l exposure group
(Figure 1a). The degree of association increases gradually
with the degree of arsenic exposure in higher exposure
groups. The fragment isolated has a higher degree of
association during hybridization with PCR product of
person with arsenic induced cancer (Figure 1b).
Our results indicated that in the GMDS mRNA dataset,
non-linearity was found when pair wise sequence diver-
gence per site corrected from Kimura-2-parameter (K2P)
distances were plotted against p-distances for both transi-
tion and transversion among the studied animal species,
but Ts sites exhibited slightly higher saturation over
Tv (Figure 2a and 2b). We have estimated Disparity
Index (DI) per site of GMDS mRNA sequences between







- (0) 0.0 0.20
+ (1) 31 0.78
+++ (4) 87 1.95
++++ (6) 223 2.56
B          C              D              E
50 -250       
b
a
250 - 500         500 -1000      500 - 1100
Figure 1 Represents the southern blots of cloned insert. a. Southern hybridization pattern of the cloned insert (OPN Aga8) to amplification
products of HpaII digested DNA from four persons of different exposure groups. b. Southern hybridization pattern of the cloned insert (OPN Aga 8)
to amplification products of HpaII digested DNA from four persons of three different exposure groups without arsenic induced cancer and one group
of arsenic induced cancer.
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ition biases, than expected. This is based on evolutionary
divergence between sequences and by chance alone. There
were a total of 670 positions in the final dataset. Highest
Disparity Index was observed between Apis florae
and Anopheles gambiae (DI = 24.38) among the other
sequence pairs (Figure 3).
Phylogenetic analysis
Human GMDS gene sequence comparison was done with
42 different species of different animal groups, for which
the sequences available in GenBank gives us the evolution-
ary relationship of this gene among the selected species
(Table 5). Multiple sequence alignment was executed with
three dataset derived from GMDS mRNA sequences using
Clustal W and it was found that the sequence identified is
conserved in a number of genera studied. The sequencewas further analyzed using the Kimura 2-parameter model,
p-distance to assay the probability of the number of transi-
tional and transversional substitutions per site between
sequences. All positions containing gaps and missing
data were eliminated. Phylogenetic tree was constructed
based on Neighbor-Joining method (NJ) with Kimura
2-parameter using MEGA version 5.05 Tamura et al.
(2011); Saha et al. 2013a, b) from both transition and trans-
version data. Standard error estimate(s) were obtained by
bootstrap procedure (1000 replicates). Disparity Index
per site was estimated for all sequence pairs Kumar and
Gadagkar (2001).
Maximum Composite Likelihood Estimate of the
pattern of nucleotide substitution was estimated according
to Tamura et al. (2004) where each entry shows the prob-
ability of substitution (r) from one base (row) to another


































Figure 2 Pairwise sequence divergence among the 42 animal taxa. GMDS mDNA, (a) and (b); plots of Kimura 2 parameter (K2P) inferred
Transition (Ts) and Transversion (Tv) distances against the P-distance.
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substitutions are shown in bold and those of trans-
versional substitutions are shown in italics. The nucleo-
tide frequencies are 28.32% (A), 26.46% (T/U), 24.03% (C),
and 21.20% (G). The transition/transversion rate ratios are
k1 = 1.887 (purines) and k2 = 3.132 (pyrimidines). The
overall transition/transversion bias is R = 1.219, where
R= [A*G*k1+T*C*k2]/[(A +G)*(T +C)]. The whole analysis
involved 42 different nucleotide sequences. All positions
containing gaps and missing data were eliminated. There
were a total of 670 positions in the final dataset.
GMDS mRNA derived phylogenetic tree inferred by
the NJ method represented in Figure 4. Due to saturation
of both the substitutions, the sum of the transition and
transversion for phylogenetic tree reconstruction by the
NJ method based on K2P model has been used. These
sequences are composed of 435 variable sites and 389
parsimony informative sites. The transition/transversion

































Figure 3 Disparity Index per site is shown for all sequence pairs for G
eliminated. Values greater than 0 indicate the larger differences in base com
between sequences and by chance alone. The analysis involved 42 nucleo0.96 and 0.333 ± 0.016. We have observed that GMDS
sequence of Callithrix jacchus shared a common
ancestor with the sister clade containing Homo sapiens,
Pan troglodytes, Pongo abelii, Nomascus leucogenys and
Macaca mulatta with 100% bootstrap support. Equus
caballus have shown monophyly with closely related sister
species Ailuropoda melanoleuca and Canis lupus which
was supported by high bootstrap value (97%). Cricetulus
griseus, Rattus norvegicus and Mus musculus formed a
monophyletic group with high bootstrap support
(100% and 99% respectively), whereas Ornithorhynchus
anatinus diverged early in the tree among all other
mammamls under study. NJ tree also depicted that
Taeniopygia guttata, Gallus gallus and Meleagris gallopavo
belong to the class Aves that have exhibited mono-
phyletic origin and evolved parallely with the reptiles
(Anolis carolinensis) but diverged after the class Amphibia
and Actinopterygii. Class Insecta belongs to the phylum





























MDS sequences. All positions containing gaps and missing data were
position biases than expected based on evolutionary divergence
tide sequences. There were a total of 670 positions in the final dataset.
Table 5 GenBank accession numbers and size of GMD
sequence of sampled taxa
Sr. No. Organism Accession No. Size
1 Homo sapiens BC000117.1 1119 bp
2 Pan troglodytes XM_518203.3 795 bp
3 Pongo abelii XM_002816345.1 1119 bp
4 Nomascus leucogenys XM_003272184.1 1119 bp
5 Macaca mulatta NM_001266789.1 1119 bp
6 Callithrix jacchus XM_002746279.2 1119 bp
7 Equus caballus XM_001490703.3 1050 bp
8 Ailuropoda melanoleuca XM_002922834.1 1119 bp
9 Canis lupus XM_545311.3 1011 bp
10 Loxodonta africana XM_003417823.1 1119 bp
11 Cavia porcellus XM_003463230.1 1050 bp
12 Bos taurus NM_001080331.1 1119 bp
13 Oryctolagus cuniculus XM_002720970.1 1662 bp
14 Cricetulus griseus NM_001246696.1 1119 bp
15 Rattus norvegicus NM_001039606.1 1119 bp
16 Mus musculus BC093502.1 1119 bp
17 Ornithorhynchus anatinus XM_001510089.1 1260 bp
18 Anolis carolinensis XM_003225586.1 1006 bp
19 Taeniopygia guttata XM_002197547.1 1035 bp
20 Gallus gallus XM_418977.3 1086 bp
21 Meleagris gallopavo XM_003204780.1 1047 bp
22 Xenopus laevis BC157411.1 1110 bp
23 Danio rerio NM_001102475.2 1113 bp
24 Salmo salar NM_001141373.1 1113 bp
25 Oreochromis niloticus XM_003457295.1 1116 bp
26 Nematostella vectensis XM_001622499.1 1077 bp
27 Trichoplax adhaerens XM_002116109.1 1080 bp
28 Brachionus manjavacas FJ829249.1 1027 bp
29 Culex quinquefasciatus XM_001868832.1 1107 bp
30 Anopheles gambiae XM_308963.3 1089 bp
31 Aedes aegypti XM_001650058.1 1149 bp
32 Tribolium castaneum XM_968229.1 1071 bp
33 Drosophila willistoni XM_002066598.1 1194 bp
34 Amphimedon queenslandica XM_003384374.1 1110 bp
35 Brugia malayi XM_001898680.1 1164 bp
36 Loa loa XM_003138092.1 1143 bp
37 Dictyostelium purpureum XM_003283436.1 1068 bp
38 Acyrthosiphon pisum XM_001949034.2 1086 bp
39 Nasonia vitripennis XM_001605356.2 1071 bp
40 Megachile rotundata XM_003702009.1 1077 bp
41 Bombus impatiens XM_003484683.1 1071 bp
42 Apis florea XM_003692995.1 1077 bp
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Brugia malayi and Loa loa are closely related providing
90% sequence similarity.
Identified sequence OPN Aga 8
TCCCTCACTA CTCAAAGTTG ATGACTTCTT
AAACCAAAAT GGTTGGTCAG AATCCAATCA


















The mechanism by which arsenic contributes to the
development of cancer is currently a subject of intense
interest. Arsenic does not act as a point mutagen.
However, metabolism of arsenic involves methylation
of inorganic arsenate to dimethyl arsinic acid via alternating
reduction of pentavalent arsenic to trivalent arsenic and
addition of methyl group (Vahter 1999; Donohue and
Abernathy 2001). The arsenic methyl transferase uses
the same methyl donor SAM as DNA methyltransferase
(Dnmt) and other methyltransferases. Interaction of arsenic
methylation/detoxification pathway with DNA methylation
pathway and consequent imbalance in DNA methylation
has been envisaged. Increase of cytosine methyltransferase
transcript after arsenic exposure has been reported
(Zhong et al. 2001), and this might explain the initial
hypermethylation through excessive induction of the
enzyme. On the other hand prolonged arsenic exposure
may cause depletion of the SAM pool due to over con-
sumption of the methyl groups by arsenic methyltransfer-
ase, and cause hypomethylation of DNA. Although we have
failed to isolate any hypomethylated fragment from patients
who have arsenic induced cancer or persons having chronic
high level of exposure with systemic manifestations, yet,
there was number of subjects with p53 promoter hypome-
thylation in our previous study (Chanda et al. 2006). In fact
decrease of tissue arsenic burden has been correlated with
methionine intake in experiments with laboratory rats
exposed to arsenic (Nandi et al. 2005). Interestingly the
Table 6 Maximum composite likelihood estimate of the
pattern of nucleotide substitution
A T C G
A - 5.91 4.73 10.12
T 6.32 - 14.82 5.36
C 6.32 18.5 - 5.36
G 11.93 5.91 4.73 -
Note: Specificity for the bold symbols are justified in result.
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http://www.springerplus.com/content/2/1/557fragment of GMDS gene isolated from subjects having high
degree of arsenic exposure and relatively high degree of p53
methylation are from male subjects except one. We had
not found any correlation between sex and p53 methylation
status in our previous study (Chanda et al. 2006). The
hypermethylated gene fragment has been isolated from
both smokers and nonsmokers although in the present











































































Figure 4 Unrooted neighbor-joining tree constructed from the GMDS
of replicate trees in which the associated taxa clustered together in the bo
evolutionary distances were computed using the Kimura 2-parameter (K2P)
site. There were a total of 670 positions in the final dataset.hypermethylation is 8 out of 10. In our previous study we
showed that there was no association between the p53 and
p16 methylation status with individual’s smoking habit. In
this study, due to small sample number, we could not carry
out statistical evaluation for correlation between smoking
habit and GMDS gene methylation. The fragment isolated
in this study is from 9 male subjects and only one female
subject out of 10 subjects. Increase in number of study
subjects and consequent rise in the number of subjects
having GMDS gene hypermethylation may provide
definite information about the association (if any) of
sex specificity of GMDS gene hypermethylation with
arsenic exposure in human.
Such aberrant methylation of the genome leading to
gene expression anomalies and have been mooted as
possible mechanism of arsenic induced carcinogenesis.
Cancer, which results from inappropriate expression of




































mDNA sequences (branch length = 4.18962548). The percentage
otstrap test (1000 replicates) is shown above the branches. The
method and are in the units of the number of base differences per
Chanda et al. SpringerPlus 2013, 2:557 Page 10 of 12
http://www.springerplus.com/content/2/1/557and/or hypermethylation of tumor suppressor genes that
can alter the level of their expression and thereby promote
cancer. In fact, there are recent observations that
widespread methylation changes occur during tumor
development (Jones and Baylin 2002).
Overall, tumor cell DNA is hypomethylated compared
to normal cell DNA and underexpression of Dnmt1 gene
causes aggressive tumor induction in genetically engineered
mice (Gaudet et al. 2003). However, for some tumor
suppressors like p16, p15 methylation is a common
alternative to point mutation and in others like RASSF1A
or H1C1, it is the only mechanism for tumor specific loss
of function (Jones and Baylin 2002). Silencing of genes like
TIMP-3 through methylation has been associated with
metastasis (Darnton et al. 2005).
Methylation of DNA is maintained by a balance of the
activity of DNA methyltransferase (Dnmt 1, Dnmt 3a
and Dnmt 3b) and DNA demethylase (mbd2) activity.
Inhibition of mbd2 by antisense expression results in
inhibition of anchorage-independent growth of antisense
transfected cancer cells or cells infected with an adeno-
viral vector expressing antisense mbd2 (Slack et al. 2002).
Expression of Dnmt mRNA is significantly high in gastric
cancer in comparison to non-cancerous gastric mucosa
(Fang et al. 2004). Similarly level of mbd2 mRNA level is
significantly lower in gastric cancer tissue than normal
gastric mucosa (Fang et al. 2004).
Previous works with human adenocarcinoma cell
line in tissue culture showed that arsenic induces
significant changes in methylation status in tumor
suppressor gene p53 Mass and Wang (1997). Later,
using arsenic exposed human kidney cell lines global
hyper and hypomethylation has been demonstrated by
the same group (Zhong et al. 2001). DNA sequencing
and SssI methylase assay were used for estimation of
genomic CpG methylation level. Arsenic exposure of
A 549 cells in culture resulted in a dose dependent
increase in cytosine methylation in p53 gene and a
small increase in global methylation Mass and Wang
(1997). Later we have shown that arsenic induces
genomic hypermethylation in chronically exposed persons
Majumder et al. (2010). An increase in the rate of tran-
scription of DNA methyltransferase gene in cells exposed
to arsenite was detected by RT-PCR (Zhong et al. 2001).
Our group has demonstrated for the first time that there
is dose dependent enhancement of methylation in the
promoter region of p53 and p16 tumor suppressor
genes of genomic DNA extracted from peripheral
blood leucocytes of persons exposed to various doses
of arsenic (Chanda et al. 2006). However, both these genes
are associated with cell cycling and repair, and the possibility
exists that methylation perturbation observed is engineered
through disturbances in cell cycle produced by arsenic,
and is local, rather than a global effect of arsenic.In the present work we have investigated that whether
there is any probable common target for aberrant DNA
methylation after arsenic exposure in exposed persons
apart from p53 or p16 gene methylation. We have
successfully identified one fragment of hypermethylated
DNA from persons exposed chronically to arsenic and per-
sons having arsenic cancer. The subjects have been chosen
from our previous study population (Chanda et al. 2006)
having hypermethylated p53 promoter region with chronic
high level of arsenic exposure with and without arsenic
induced cancer. Therefore persons having GMDS gene
intron hypermethylation also have p53 promoter hyperme-
thylation. Thus this study reflects an association between
the p53 promoter hypermethylation with GMDS gene
intron hypermethylation in chronic high level of arsenic
exposed people. The fragment was isolated from both per-
ipheral blood leukocyte DNA and from cancer biopsy tissue
of persons having arsenic induced cancer. The hypermethy-
lated DNA fragment is from GMDS gene responsible for
fucose metabolism. GMDS is the binding partner of tankyr-
ase which is needed to be associated for the first step of
fucose biosysnthesis (Bisht et al. 2012). Oligosaccharides
are involved in various aspects of life process including
birth, differentiation, growth, inflammation, carcinogenesis,
and cancer metastasis. Fucosylation is one of the most
important oligosaccharide modifications in cancer. This
type of glycomodification can be treated as a biomarker in
cancer (Moriwaki et al. 2009; Miyoshi et al. 2012).
Fucosylated alpha-fetoprotein (AFP) is widely used in
the diagnosis of hepatocellular haptoglobin have also
been found in sera of patients with various carcinomas
(Miyoshi et al. 2012). Deletion mutation of the GMDS
gene plays a pivotal role in fucosylation in human colon
cancer. Loss of function mutation of this gene may lead
to a virtually complete deficiency of cellular fucosylation,
tumor progression and metastasis (Nakayama et al. 2013)
and transfection of the wild-type GMDS into HCT116
cells restored the cellular fucosylation. This type of
GMDS mutation resulted in resistance to TRAIL-induced
apoptosis followed by escape from immune surveillance
(Moriwaki et al. 2009; Haltiwanger 2009; Moriwaki et al.
2011) and thus promote carcinogenesis. Further, epigen-
etic regulation of fucosylation and TRAIL induced apop-
tosis in conjunction to cancer had been studied by same
group (Moriwaki et al. 2010). Although in the present
study we have not shown any association with the level of
fucose in patients with GMDS gene hypermethylation, but
still GMDS gene fragment hypermethylation is associated
with p53 hypermethylation with development of arsenic
induced cancer (in group E) or severe skin manifestations
(in group D) as a result of chronic high level of
exposure. In the present study we have not work out the
degree of correlation (if any,) between the GMDS intron
hypermethylation and p53 promoter hypermethylation,
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has not been studied here), although this study signifies
the association between p53 promoter hypermethylation
and GMDS gene hypermethylation after chronic arsenic
exposure.
The intronic fragment isolated in the present study
showed hypermethylation in comparison to normal unex-
posed subjects. This epigenetic modification may be involve
in transcriptional modification and may modify the ultim-
ate cellular level of GMDS enzyme. As it is reported that
aberrant methylation of introns or intergenic regions can
regulate non coding RNA function to modify the degree of
transcription of a gene and the exonal expression is
dependent over the local methylation status rather than the
promoter region (Cheung et al. 2011). Consequences of
intron methylation have also been studied by Hoivik et al.
(2011) and Jowaed et al. (2010) in two separate studies
where it was reported that intron methylation is associated
with altered expression. Moreover, dense methylation sur-
rounding transcription start site or near the first exon is
tightly linked with gene silencing (Brenet et al. 2011).
Till to date this is the first report of GMDS intron
hypermethylation in chronic arsenic exposure with and
without malignancy. Reports are also unavailable regarding
association between p53, p16 gene hypermethylation and
GMDS gene hypermethylation in human cancer as well as
in arsenic induced cancer.
During the initial stage of the experiments we did
observe some bands of hypomethylation, but we failed to
clone them. It might be mentioned that in our previous
investigations too, we observed far fewer hypomethylation
cases. It is postulated that overexposure of arsenic and its
biotransformation causes depletion of SAM, leading to
hypomethylation of DNA. Hence extensive hypomethyla-
tion probably needs a very high exposure, which is achieved
in artificial tissue culture systems, but rarely in real life situ-
ation. In the tissue culture experiments too, the study with
cells exposed to arsenite for 2–4 weeks observed mostly
hypermethylation and a few hypomethylation cases (Zhong
et al. 2001). Chronic exposure of 18 weeks at low dose, on
the other hand produced extensive hypomethylation and
transformation in rat hepatocyte cell line (Zhao et al. 1997).Conclusion
To sum up, this is the first report of GMDS gene
fragment hypermethylation in the peripheral blood
leukocyte DNA of persons exposed to arsenic. To ascertain
this fragment of hypermethylation as a biomarker for arsenic
induced cancer and chronic arsenic exposure researchers
require repetition of such work in large sample group.Competing interests
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